Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO
- 1 December 1997
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 30 (6), 912-922
- https://doi.org/10.1016/s0272-6386(97)90104-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietinKidney International, 1989
- USA Multicenter Clinical Trial with Recombinant Human Erythropoietin (Amgen)Published by S. Karger AG ,1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Anemia of end-stage renal disease (ESRD)Kidney International, 1985
- Search for the Uremic ToxinNew England Journal of Medicine, 1978
- Iron Balance in Hemodialysis PatientsAnnals of Internal Medicine, 1977
- The kidney and erythropoiesisAmerican Journal Of Medicine, 1968
- Haemolysis in chronic renal failure.BMJ, 1967
- Megaloblastic Hematopoiesis in Uremia and in Patients on Long-Term HemodialysisNew England Journal of Medicine, 1967
- THE BLEEDING DISORDER OF URÆMIA: A Qualitative Platelet DefectThe Lancet, 1966